Evidence map›Paper›PMID 40658203›Full record

ReviewPathologie (Heidelberg, Germany)2025

[Pathology of liver tumours in animal models].

Thomas Metzler, Margaret Tulessin, Tanja Groll, Mahsa Rezvan, Anna-Chiara Riedl, Heike Aupperle-Lellbach, Robert Klopfleisch, Carolin Mogler, Katja Steiger

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Pathologie (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Thomas MetzlerVergleichende experimentelle Pathologie (CEP), School of Medicine and Health, Technische Universität München, München, Deutschland.
Margaret TulessinVergleichende experimentelle Pathologie (CEP), School of Medicine and Health, Technische Universität München, München, Deutschland.
Tanja GrollVergleichende experimentelle Pathologie (CEP), School of Medicine and Health, Technische Universität München, München, Deutschland.
Mahsa RezvanVergleichende experimentelle Pathologie (CEP), School of Medicine and Health, Technische Universität München, München, Deutschland.
Anna-Chiara RiedlLaboklin GmbH, Bad Kissingen, Deutschland.
Heike Aupperle-LellbachVergleichende experimentelle Pathologie (CEP), School of Medicine and Health, Technische Universität München, München, Deutschland.
Robert KlopfleischInstitut für Tierpathologie, Freie Universität Berlin, Berlin, Deutschland.
Carolin MoglerVergleichende experimentelle Pathologie (CEP), School of Medicine and Health, Technische Universität München, München, Deutschland.
Katja SteigerVergleichende experimentelle Pathologie (CEP), School of Medicine and Health, Technische Universität München, München, Deutschland. katja.steiger@tum.de.ORCID http://orcid.org/0000-0002-7269-5433

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLiver tumours are common and deadly diseases in humans and are often associated with a poor prognosis. To better understand the mechanisms and potential therapies for hepatocellular carcinoma and cholangiocarcinoma, experimental animal models are used in preclinical research and spontaneously occurring tumours in companion animals can also be investigated as models.

objectiveWe provide an overview of commonly used animal models in hepatic cancer research, including their applications, advantages, and disadvantages. Additionally, we present pathological findings of the most frequent spontaneous liver neoplasms in dogs and cats. MATERIALS AND

methodsWe performed a review of the scientific literature and of findings in animal models. Additionally, we performed an analysis of case statistics from a veterinary pathology submission laboratory.

resultsMouse models are most frequently used in the study of hepatic tumours. These include xenografts, in which human tumour cells are injected, chemically and diet-induced models for studying environmental and metabolic factors, and genetically modified mice. In addition to mice, other species such as rats, rabbits, and woodchucks are also utilized. Woodchucks carry their own hepatitis virus, making them particularly suitable for investigating viral pathogenesis. Furthermore, domestic animals such as dogs and cats develop spontaneous liver neoplasms, which makes them valuable models. Dogs predominantly develop hepatocellular adenomas and carcinomas, whereas benign, cystic bile duct lesions are more common in cats.

conclusionsA wide range of animal models is available for various research questions. Choosing the appropriate model is crucial for the success of any study and depends on multiple factors.

Indexed as

Disease Models, AnimalLiver NeoplasmsLiver Neoplasms, ExperimentalAnimalsBile Duct NeoplasmsCarcinoma, HepatocellularCat DiseasesCatsCholangiocarcinomaDog DiseasesDogsHumansLiverMarmotaMiceRabbitsComparative pathologyInterfaceMouse modelsSpontaneous liver tumours in companion animalsVeterinary pathology

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.